Can I Take Glycine With Jatenzo? A Clinical Review of Safety, Interactions, and Monitoring

What Jatenzo Is and How It Works

Jatenzo is the first FDA-approved oral testosterone replacement therapy to use a self-emulsifying drug delivery system that absorbs through intestinal lymphatics rather than the hepatic portal vein. The FDA granted approval in March 2019 for adult males with primary or hypogonadotropic hypogonadism [1].

Absorption Pathway: Why Food Matters

Because Jatenzo bypasses first-pass hepatic metabolism, its bioavailability depends heavily on co-ingestion with a fatty meal. The prescribing label specifies at least 19 grams of fat at each dose [1]. A pharmacokinetic study supporting the approval (N=166 hypogonadal men) showed that twice-daily dosing of 237 mg produced mean steady-state testosterone concentrations within the normal adult male range of 300 to 1,000 ng/dL [1].

This absorption route matters for the glycine question. Glycine is a water-soluble amino acid transported across the intestinal brush border by the sodium-dependent neutral amino acid transporter SLC6A9 and related carriers [2]. That pathway is entirely separate from the lymphatic chylomicron route Jatenzo uses. The two molecules do not compete for absorption.

Hepatic and Cardiovascular Considerations

Oral testosterone undecanoate does not carry the same hepatotoxicity risk seen with 17-alpha-alkylated androgens such as methyltestosterone [3]. However, Jatenzo carries an FDA boxed warning for blood pressure increases. In the key LIBERTY trial (N=166), 21.5% of participants required new or intensified antihypertensive medication during the study period [4]. Prescribers must measure blood pressure at each visit during the first three to six months.

What Glycine Is and Why People Take It

Glycine is the simplest amino acid. The human body synthesizes roughly 3 g per day endogenously, well below the estimated 10 g needed for full metabolic demand, creating a conditional requirement that diet or supplements may address [5].

Common Supplementation Reasons

Men on testosterone replacement therapy often add glycine for three specific reasons:

• Sleep quality: Several randomized trials show 3 g of glycine at bedtime shortens sleep-onset latency and improves subjective sleep quality [6].
• Collagen support: Glycine makes up roughly one-third of collagen's amino acid content by mass, and supplemental glycine may support connective tissue during resistance training [7].
• Metabolic health: Glycine plays a role in glutathione synthesis and has been studied for its effects on insulin sensitivity [8].

Glycine's Receptor Pharmacology

Glycine acts as an inhibitory neurotransmitter in the spinal cord and brainstem via strychnine-sensitive glycine receptors (GlyR). In the forebrain, it acts as a co-agonist at N-methyl-D-aspartate (NMDA) receptors. These central nervous system roles underlie its sleep-promoting effects. Neither receptor type overlaps with androgen receptor signaling, which is the primary pathway through which testosterone exerts its effects.

Pharmacokinetic Interaction: Is There One?

Short answer: No. No published pharmacokinetic study has identified a clinically meaningful interaction between glycine and testosterone undecanoate in any formulation.

Absorption Competition

As noted, Jatenzo absorbs via intestinal lymphatics packaged in chylomicrons alongside dietary fat. Glycine, being hydrophilic, is absorbed via sodium-coupled amino acid transporters in the small intestine mucosa [2]. Taking both simultaneously does not create a competition scenario. A fatty meal that satisfies Jatenzo's 19 g fat requirement does not reduce glycine absorption.

Protein Binding

Testosterone in circulation is approximately 44% bound to sex hormone-binding globulin (SHBG) and roughly 54% bound to albumin, leaving approximately 2% as free testosterone [9]. Glycine does not bind to SHBG or meaningfully compete for albumin binding sites. No displacement interaction is expected at supplemental doses of 3 to 10 g.

CYP Enzyme Effects

Testosterone is metabolized primarily by CYP3A4 [3]. Glycine has no documented inhibitory or inducing effect on CYP3A4, CYP2C9, or other major hepatic enzymes at typical supplemental doses. The interaction databases maintained by the NIH National Library of Medicine and the FDA Drug Interaction Labeling Guidance do not list glycine as a CYP modulator [10].

Pharmacodynamic Overlaps: Where to Pay Attention

Even without a pharmacokinetic interaction, two substances can produce additive, synergistic, or opposing effects at the physiological level. Three pharmacodynamic domains deserve attention here.

Blood Glucose and Insulin Sensitivity

Testosterone therapy in hypogonadal men generally improves insulin sensitivity. A 2011 meta-analysis in the European Journal of Endocrinology (12 randomized controlled trials, N=551) found that testosterone treatment reduced fasting insulin and HOMA-IR in men with metabolic syndrome [11]. Glycine, through its role as a precursor to glutathione and via direct action on pancreatic beta cells, may also improve glycemic markers. A 2009 study (N=60) published in Nutrition & Metabolism found that glycine supplementation at 5 g daily for three months reduced HbA1c by 0.4 percentage points in patients with type 2 diabetes (P<0.05) [8].

The overlap is generally favorable for metabolic health. However, men taking insulin or sulfonylureas alongside Jatenzo should be aware that both testosterone therapy and glycine may independently lower blood glucose. Combined use could increase the risk of hypoglycemia in that subset. Monitoring fasting glucose quarterly is reasonable for any hypogonadal man on testosterone replacement, as recommended by the Endocrine Society guideline [12].

Sleep Architecture and Testosterone Production

The relationship between sleep and testosterone is bidirectional. In a landmark study published in the Journal of the American Medical Association (N=10 healthy young men), sleep restriction to 5 hours per night for one week reduced daytime testosterone levels by 10 to 15% (P<0.05) [13]. Improving sleep quality is therefore not merely a comfort issue for men on TRT; it supports the endocrine milieu in which Jatenzo operates.

Glycine's documented sleep benefit is modest but consistent. A 2012 double-blind crossover trial (N=11) found that 3 g of glycine before bed reduced fatigue scores and improved polysomnographic sleep efficiency [6]. A separate study measuring core body temperature found that glycine lowered rectal temperature during sleep onset, consistent with the peripheral vasodilation mechanism thought to underlie its soporific effect [14].

No evidence suggests glycine disrupts testosterone secretion directly. Combining Jatenzo with bedtime glycine at 3 g appears unlikely to create any adverse pharmacodynamic interaction related to sleep.

Collagen, Connective Tissue, and Androgen Anabolism

Testosterone promotes muscle protein synthesis and, at physiological levels, supports tendon and ligament health [15]. Glycine, as the primary structural amino acid in collagen, is taken by many men on TRT to support connective tissue adaptation during resistance training.

A 2019 randomized controlled trial in the British Journal of Nutrition (N=97) found that collagen peptide supplementation, which delivers a glycine-rich amino acid profile, significantly increased collagen synthesis markers compared to placebo in recreationally active men [7]. Testosterone and glycine appear to work on different but complementary aspects of tissue remodeling. There is no evidence of antagonism in this domain.

HealthRX Clinical Decision Framework: Glycine Use During Jatenzo Therapy

| Patient Profile | Glycine Use Consideration | Monitoring Action | |---|---|---| | No comorbidities, on Jatenzo for hypogonadism only | Glycine 3 g at bedtime is low-risk | Standard Jatenzo monitoring; no extra labs | | Insulin resistance or prediabetes | Glycine may improve glycemic markers; low hypoglycemia risk unless on secretagogues | Quarterly fasting glucose, HbA1c at 6 months | | Type 2 diabetes on insulin or sulfonylurea | Additive glucose-lowering possible | Increase self-monitoring of blood glucose; notify prescriber | | Sleep apnea (on CPAP) | Glycine sleep benefit could complement CPAP adherence; no known interaction | Re-check hematocrit at 3 months per standard care | | Elevated blood pressure (Jatenzo boxed warning applies) | Glycine does not raise blood pressure; no concern in this domain | Blood pressure at every visit during months 1 to 6 |

Dose Timing: Does It Matter When You Take Glycine?

Jatenzo must be taken with food, twice daily, approximately 6 to 8 hours apart. The prescribing information does not specify any supplement separation window because no food-based pharmacokinetic interaction with glycine has been identified [1].

Practical Timing Recommendations

For sleep-focused glycine use, the most studied protocol is 3 g taken 30 to 60 minutes before bedtime [6]. Jatenzo doses are typically taken with breakfast and dinner. Those meal windows do not overlap with a bedtime glycine dose in most patients, making the timing question largely irrelevant in real-world use.

For collagen-support use (typically 5 to 10 g glycine or a collagen peptide product taken 30 to 60 minutes before exercise), there is also no timing conflict with Jatenzo's twice-daily meal-based dosing.

What About High-Protein Meals?

Some patients wonder whether a high-protein breakfast required to co-administer glycine would affect Jatenzo absorption. The prescribing information specifies fat content as the key variable, not protein content [1]. A meal containing 19 g of fat plus protein-rich foods, including glycine supplementation mixed into a shake, should not impair Jatenzo absorption. Patients should confirm the fat content of their meal rather than focusing on its protein composition.

Safety Signals and What the Literature Does Not Show

No randomized controlled trial has directly studied glycine co-administration in men taking Jatenzo or any oral testosterone undecanoate formulation. The absence of a published study is not itself a safety signal. Glycine has a well-characterized safety profile at doses up to 90 g per day in clinical studies of schizophrenia and other conditions [16]. At the 3 to 10 g doses used for sleep and collagen support, adverse effects reported in trials are generally limited to mild gastrointestinal discomfort.

What the FDA Label Does and Does Not Say

The FDA-approved Jatenzo prescribing label lists specific drug interactions with insulin, oral hypoglycemics, anticoagulants (due to testosterone's effect on clotting factors), corticosteroids, and CYP3A4 inhibitors/inducers [1]. Glycine appears nowhere in that list. The label's drug interaction section reflects the evidence available at approval; it does not imply that every unlisted substance is risk-free, but the absence of a listing combined with glycine's distinct pharmacological profile is reassuring.

Hematocrit Monitoring Remains Essential

Testosterone therapy, including Jatenzo, raises hematocrit. The Endocrine Society guideline states: "We recommend checking hematocrit at baseline, at 3 to 6 months, and then annually" [12]. Glycine does not affect erythropoiesis and does not alter this monitoring schedule. Men whose hematocrit exceeds 54% should have Jatenzo held regardless of supplement use.

What to Tell Your Prescriber

Transparency about supplement use matters because prescribers calculate cardiovascular risk, adjust Jatenzo doses based on trough testosterone levels, and monitor for the boxed-warning blood pressure increase. Glycine is unlikely to complicate any of those assessments, but your prescriber cannot make informed decisions with incomplete information.

Information to Bring to Your Appointment

• The brand and form of glycine you use (powder, capsule, collagen peptide product)
• Your daily dose in grams
• The time of day you take it
• Any other supplements or over-the-counter products in your regimen

A 2020 survey published in the Journal of Clinical Endocrinology and Metabolism found that fewer than 30% of men on TRT disclosed all supplement use to their prescribers [17]. Disclosure does not require the supplement to be dangerous; it allows your provider to build a complete clinical picture.

Monitoring Schedule for Men on Jatenzo Who Also Take Glycine

The standard Jatenzo monitoring schedule, as specified in the prescribing label and the Endocrine Society 2018 guideline, does not change because of glycine supplementation. For reference:

• Testosterone trough level: 3 to 6 months after starting or any dose change, then annually
• Blood pressure: every clinic visit during the first 3 to 6 months
• Hematocrit: 3 to 6 months after initiation, then annually
• Lipid panel: annually (testosterone can reduce HDL in some formulations)
• PSA: per age-appropriate prostate cancer screening guidelines

Men with insulin resistance or type 2 diabetes who add glycine should discuss adding quarterly fasting glucose checks with their prescriber, given the independent glycemic effects of both testosterone and glycine.